[{"id":"3042bfbf-c727-461b-bbc1-643e31726fae","acronym":"BBMPI03","url":"https://clinicaltrials.gov/study/NCT02240537","created_at":"2021-06-30T14:52:42.051Z","updated_at":"2024-07-02T16:37:32.661Z","phase":"Phase 1","brief_title":"Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer","source_id_and_acronym":"NCT02240537 - BBMPI03","lead_sponsor":"Benovus Bio, Inc.","biomarkers":" HLA-A","pipe":" | ","alterations":" HLA-A*02","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BB-MPI-03 • Leukine (sargramostim)"],"overall_status":"Unknown status","enrollment":" Enrollment 4","initiation":"Initiation: 01/01/2015","start_date":" 01/01/2015","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 06/01/2017","study_completion_date":" 06/01/2017","last_update_posted":"2016-04-19"}]